LLY · Eli Lilly
Latest news, signals, and AI analysis for Eli Lilly (LLY) on Catalayer. Updated continuously as stories are indexed across our news feed.
Recent LLY News
Prediction: Here's What a $5,000 Investment in Eli Lilly Could Look Like in 5 Years
Will Eli Lilly Split Its Stock? Here's What History Says Will Happen If It Does.
Eli Lilly’s $100B incretin opportunity: Is more upside coming?
Eli Lilly Stock Is Not Done Growing Yet, But It's Due For Compression (Rating Downgrade)
Related Tickers
$JNJ · Johnson & Johnson$PFE · Pfizer$MRK · Merck$ABBV · AbbVie$NVO · Novo Nordisk$GILD · Gilead SciencesFrequently Asked Questions
What sector does LLY belong to?
LLY (Eli Lilly) is classified under the Pharma sector on Catalayer. You can browse all news in this sector at /sector/pharma.
Where can I track real-time LLY news?
Catalayer aggregates LLY coverage from Reuters, Bloomberg, CNBC, MarketWatch, Yahoo Finance, Seeking Alpha, Barron’s, WSJ, Motley Fool, Benzinga, TipRanks and 20+ other sources. View the live feed at https://catalayer.com/stocks/LLY.
How fast are LLY news alerts on Catalayer?
News is polled every 30–60 seconds. LLY-related stories appear in your workspace within minutes of publication, and you can create a custom monitor to get instant alerts.
Does Catalayer provide AI analysis for LLY?
Yes. The Market Intelligence tier adds AI-powered event classification (monetary policy, earnings, guidance, M&A), directional impact (bullish/bearish), magnitude, and affected-sector analysis to every LLY story.
Is LLY covered in any Catalayer signal channels?
Signal channels and custom keyword monitors both support LLY. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 monitors with boolean rules across tickers, sectors, and topics.